Human — controlled trial

Randomised controlled trials of semaglutide, the approved medicine

An extensive randomised controlled trial literature exists for the approved pharmaceutical product, conducted under medical supervision with a product of verified identity and purity. It is evidence about that product, not about research-grade material of unverified content.

Placeholder record

This entry marks a body of literature and where to find it rather than a single paper. It is kept out of search indexes until it is replaced by a full record.

Cited by

Semaglutide
What the research on semaglutide actually shows
Semaglutide has one of the strongest human evidence bases of any compound in this index — and none of it attaches to research-grade powder. The randomised controlled trials were run on an approved pharmaceutical product of verified identity and purity, administered under medical supervision. Material sold for research use is not that product, and the trial evidence does not transfer to it. What a research-grade vial contains is established only by its certificate of analysis, if one exists.

Compounds examined

Semaglutide

Study records state what a paper reported. PepIndex does not interpret findings, assess clinical significance, or restate results in language implying an application not present in the source. Last reviewed 23 Jul 2026.